Pisano Wayne — SEC insider filings

SEC reporting owner CIK 1743611. 17 insider filings on record with FilingPulse; latest filed 2026-11-13.

Transaction summary — filings shown

Covers all 17 filings on record, filed 2020-09-28 to 2026-11-13. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Altimmune, Inc. (ALT)Director122 legs · 15,000 sh · $36,7602 legs · 30,352 sh · $402,75311
ONCOLYTICS BIOTECH INC (ONCY)Director21 leg · 30,000 sh · $25,338—1
Provention Bio, Inc. (PRVB)Director3——8

Insider filings — Pisano Wayne

FiledFormIssuerReported transactionsSource
2026-11-134Altimmune, Inc. (ALT)Purchase (P): 10,000 @ $1.64EDGAR
2026-06-034ONCOLYTICS BIOTECH INC (ONCY)Grant/award (A): 30,000 (derivative) @ $0EDGAR
2026-05-014Altimmune, Inc. (ALT)Grant/award (A): 48,800 (derivative) @ $0EDGAR
2026-02-134ONCOLYTICS BIOTECH INC (ONCY)Purchase (P): 30,000 @ $0.84EDGAR
2026-01-094Altimmune, Inc. (ALT)Purchase (P): 5,000 @ $4.08EDGAR
2025-09-294Altimmune, Inc. (ALT)Grant/award (A): 48,800 (derivative) @ $0EDGAR
2024-09-304Altimmune, Inc. (ALT)Grant/award (A): 34,900 (derivative) @ $0EDGAR
2023-09-294Altimmune, Inc. (ALT)Grant/award (A): 26,100 (derivative) @ $0EDGAR
2023-04-274Provention Bio, Inc. (PRVB)Code (U): 7,500 · Disposition to issuer (D): 128,981 (derivative) · Disposition to issuer (D): 24,000 (derivative) · Disposition to issuer (D): 22,200 (derivative) · Disposition to issuer (D): 23,000 (derivative) · Disposition to issuer (D): 33,000 (derivative)EDGAR
2022-12-224Altimmune, Inc. (ALT)Option exercise (M): 20,000 @ $2.60 · Sale (S): 20,000 @ $15.01 · Option exercise (M): 20,000 (derivative) @ $0EDGAR
2022-09-304Altimmune, Inc. (ALT)Grant/award (A): 23,500 (derivative) @ $0EDGAR
2022-05-184Provention Bio, Inc. (PRVB)Grant/award (A): 33,000 (derivative) @ $0EDGAR
2021-09-244Altimmune, Inc. (ALT)Grant/award (A): 24,100 (derivative) @ $0EDGAR
2021-05-144Provention Bio, Inc. (PRVB)Grant/award (A): 23,000 (derivative) @ $0EDGAR
2020-11-134Altimmune, Inc. (ALT)Sale (S): 10,352 @ $9.90EDGAR
2020-10-164Altimmune, Inc. (ALT)Option exercise (M): 16,850 @ $0 · Option exercise (M): 16,850 (derivative) @ $0EDGAR
2020-09-284Altimmune, Inc. (ALT)Grant/award (A): 25,500 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2020-09-28 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1743611 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs